Pathological Complete Response in Neoadjuvant Treatment of Breast Cancer

被引：0
|
作者：
Patricia Cortazar
Charles E. Geyer
机构：
[1] U.S. Food and Drug Administration,Office of Hematology and Oncology Products, Center for Drug Evaluation and Research
[2] Virginia Commonwealth University,Massey Cancer Center
来源：
Annals of Surgical Oncology | 2015年 / 22卷
关键词：
Overall Survival; Trastuzumab; Lapatinib; Pertuzumab; Locally Advanced Breast Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1441 / 1446
页数：5
相关论文
共 50 条
  • [1] Pathological Complete Response in Neoadjuvant Treatment of Breast Cancer
    Cortazar, Patricia
    Geyer, Charles E., Jr.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (05) : 1441 - 1446
  • [2] Total pathological complete response versus breast pathological complete response in clinical trials of reference and biosimilar trastuzumab in the neoadjuvant treatment of breast cancer
    Stebbing, Justin
    Baranau, Yauheni
    Manikhas, Alexey
    Lee, Sang Joon
    Thiruchelvam, Paul
    Leff, Daniel
    Esteva, Francisco J.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (06) : 531 - 541
  • [3] Relevance of Pathological Complete Response after Neoadjuvant Therapy for Breast Cancer
    Pennisi, Angela
    Kieber-Emmons, Thomas
    Makhoul, Issam
    Hutchins, Laura
    [J]. BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2016, 10 : 103 - 106
  • [4] Biomarkers Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
    Li, Xiaoxian
    Krishnamurti, Uma
    Bhattarai, Shristi
    Klimov, Sergey
    Reid, Michelle
    Aneja, Ritu
    [J]. LABORATORY INVESTIGATION, 2016, 96 : 54A - 54A
  • [5] Biomarkers Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
    Li, Xiaoxian
    Krishnamurti, Uma
    Bhattarai, Shristi
    Klimov, Sergey
    Reid, Michelle
    Aneja, Ritu
    [J]. MODERN PATHOLOGY, 2016, 29 : 54A - 54A
  • [6] Pathological Complete Response Patients after Neoadjuvant Chemotherapy in Breast Cancer
    Takaoka, Megumi
    Ohsumi, Shozo
    Ikejiri, Haruka
    Shidahara, Tomohiro
    Miyoshi, Yuichiro
    Takahashi, Mina
    Takashima, Seiki
    Aogi, Kenjiro
    [J]. ACTA MEDICA OKAYAMA, 2022, 76 (02) : 105 - 111
  • [7] Pathological complete response in breast cancer patients receiving neoadjuvant chemotherapy
    Montemurro, Filippo
    Di Cosimo, Serena
    [J]. BREAST, 2014, 23 (05): : 690 - 691
  • [8] Identification of tumor biomarkers for pathological complete response to neoadjuvant treatment in locally advanced breast cancer
    Gopinath, Prarthana
    Veluswami, Sridevi
    Gopisetty, Gopal
    Sundersingh, Shirley
    Rajaraman, Swaminathan
    Thangarajan, Rajkumar
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2022, 194 (02) : 207 - 220
  • [9] Identification of tumor biomarkers for pathological complete response to neoadjuvant treatment in locally advanced breast cancer
    Prarthana Gopinath
    Sridevi Veluswami
    Gopal Gopisetty
    Shirley Sundersingh
    Swaminathan Rajaraman
    Rajkumar Thangarajan
    [J]. Breast Cancer Research and Treatment, 2022, 194 : 207 - 220
  • [10] PATHOLOGICAL COMPLETE RESPONSE RATE BY SUB-TYPES AFTER NEOADJUVANT TREATMENT FOR BREAST CANCER
    Bourbonnais, A.
    Prady, C.
    Fox, S.
    Desjardins, P.
    Simon, R.
    Matte, C.
    Billy, M.
    Latreille, J.
    [J]. BREAST, 2013, 22 : S100 - S100
12345